View of Cost-effectiveness analysis and budget impact analysis of next-generation sequencing panel including BRCA1 and BRCA2 genes for women diagnosed with non-metastatic breast cancer in Brazil

Return to Article Details Cost-effectiveness analysis and budget impact analysis of next-generation sequencing panel including BRCA1 and BRCA2 genes for women diagnosed with non-metastatic breast cancer in Brazil Download Download PDF